1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Encorafenib with binimetinib for treating BRAF V600E mutation-positive advanced non-small-cell lung cancer [ID6177]

In development [GID-TA11140] Expected publication date: 23 July 2025

  • Project information
  • Project documents

Documents

A list of downloadable documents created during development.

Invitation to participate

  • Final scope PDF 182 KB 01 October 2024  
  • Final stakeholder list PDF 184 KB 01 October 2024  
  • NICE's response to comments on the draft scope and provisional stakeholder list PDF 220 KB 01 October 2024  
  • Equality impact assessment (scoping) PDF 125 KB 01 October 2024